AndrewBrohlMD

Hematologic Oncology, Melanoma, Sarcoma

Physician

Overview of Dr. Brohl

Dr. Andrew Brohl is an oncologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from University of Miami Leonard M. Miller School of Medicine and has been in practice 11 years. Dr. Brohl accepts several types of health insurance, listed below. He is one of 170 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in Oncology. He has more than 70 publications and over 500 citings.

Office
12902 Usf Magnolia Dr
Tampa, FL 33612
Book by Phone+1(607) 350-2972

Fax+1 813-745-8337

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2006 - 2009
University of Miami Leonard M. Miller School of MedicineClass of 2006

Certifications & Licensure

FL State Medical License 2015 - 2025
NY State Medical License 2013 - 2017
VA State Medical License 2006 - 2014
DC State Medical License 2006 - 2010
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients Start of enrollment: 2020 Dec 22
Active, not recruiting
Phase 2
IL2 With Ipilimumab Followed by Nivolumab in Stage 3 or 4 Melanoma Patients Start of enrollment: 2020 Sep 24
Recruiting
Phase 2
Adjuvant Therapy Based on Pathologic Response After Neoadjuvant Encorafenib Binimetinib in Melanoma Start of enrollment: 2021 May 24
Recruiting
Early Phase 1
Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma Start of enrollment: 2021 Oct 22
Recruiting
Phase 1
Join now to see all

Publications & Presentations

PubMed

284 citations
Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma.
Megan H. Pollack, Allison S. Betof, Helen Dearden, K. Rapazzo, I. Valentine
Annals of Oncology. 2018-01-01
28 citations
Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis.
Goodwin G Jinesh, Andrew S Brohl
Signal Transduction and Targeted Therapy. 2022-08-23
31 citations
Immuno-transcriptomic profiling of extracranial pediatric solid malignancies.
Andrew S. Brohl, Sivasish Sindiri, Jun Wei, David Milewski, Hsien-Chao Chou
Cell Reports. 2021-11-23

Journal Articles

Identification of a Novel MTAP-RAF1 Fusion in a Soft Tissue Sarcoma
Andrew Brohl, MD, BioMed Central

Press Mentions

Tampa-Based Morphogenesis Seeks Skin Cancer Patients for New Clinical TrialsJune 16th, 2020
Genomic Landscape of Merkel Cell CarcinomaAugust 23rd, 2019
Moffitt Researchers Complete Largest Genomic Analysis of Merkel Cell Carcinoma PatientsAugust 20th, 2019
Join now to see all

Professional Memberships

Insurance Accepted

Aetna Choice POS II
Aetna HMO
Anthem KeyCare PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
First Health PPO
Great West PPO
Multiplan PHCS PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
WEA Trust Preferred Provider Plan - Trust Pref
Please verify your coverage with the provider's office directly when scheduling an appointment